The number of mentions around Biosimilars decreased by 9% in company filings in the North America region, reaching 9,232 mentions in 2023
In terms of Compound Annual Growth Rate (CAGR), the number of theme mentions reflected a growth rate of 7% between 2019 and 2023
Since 2019, Biosimilars has been mentioned 42,660 times in company filings, with 9,481 mentions in the current year (till Dec 2023). The year with the most number of related theme mentions was 2022 with 9,481 related theme mentions in the company filings. Since 2019, the average number of Biosimilars mentions has stood at approximately 7,110 in company filings.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer